Corresponding Author: Harlan M. Krumholz, MD, SM, Cardiovascular Section, Yale University School of Medicine, 1 Church St, Ste 200, New Haven, CT 06510 (firstname.lastname@example.org).
Published Online: May 27, 2013. doi:10.1001/jamainternmed.2013.6057
Study concept and design: Krumholz.
Acquisition of data: Krumholz.
Analysis and interpretation of data: All authors.
Drafting of the manuscript: Krumholz.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Jones and Li.
Obtained funding: Krumholz and Spertus.
Administrative, technical, and material support: Spertus.
Study supervision: Krumholz.
Conflict of Interest Disclosures: Dr Krumholz chairs a cardiac scientific advisory board for UnitedHealth and is the recipient of a research grant, through Yale University, from Medtronic. Dr Spertus has received grant support from Lilly, Genentech, and EvaHeart. He serves on a cardiac scientific advisory board for UnitedHealth, and as a consultant to Genentech, Amgen, and St Jude Medical. He has an equity position in Health Outcomes Sciences and owns the copyrights to the Seattle Angina Questionnaire, Kansas City Cardiomyopathy Questionnaire, and Peripheral Artery Questionnaire.
Funding/Support: The TRIUMPH study was supported by grant P50 HL077113 from the Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease from the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, Maryland. PREMIER was funded by CV Therapeutics Inc, Palo Alto, California. This study was also funded in part by CV Outcomes Inc, Kansas City, Missouri. Dr Krumholz receives funding from grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the NHLBI. During the time that this work was conducted, Dr Barreto-Filho was a postdoctoral fellow at Yale University supported by grant 3436-10-1 from CAPES (Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Ministry of Education, Brazil). Dr Spertus has received funding from the NHLBI, the American Heart Association in Dallas, Texas, and the American College of Cardiology Foundation in Washington, DC.
Role of the Sponsors: The funding sponsors had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Additional Information: Dr Barreto-Filho is now with the Division of Cardiology, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
Additional Contributions: We gratefully acknowledge the contributions of Vishnu Patlolla, MD, Gregory Mulvey, MD, and Marian Mocanu, MD.